Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

COSMIC

Financiado

Cerrado

COmbatting disorders of adaptive immunity with Systems MedICine

Background: EU countries face large health challenges to combat chronic diseases. Recently, systems medicine has emerged as a promising discipline to accelerate the translation of basic research into applications for improved diag... ver más

30/09/2022

AMC Medical Resear...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

AMC MEDICAL RESEARCH BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 21 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-09-30

MSCA-ITN-2017: Innovative Training Networks

I+D

Cerrada hace 8 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

21 Participantes

AMC Medical Research B.V.

766.12K€ | Lider

BSH UFESA INDUSTRIAL

160.47K€ | Participante

THE BABRAHAM INSTITUTE

273.29K€ | Participante

HZI

498.43K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NIMSB NOVA Institute for Medical Systems Biology 15M€ Cerrado

SYSCID A Systems medicine approach to chronic inflammatory disease 16M€ Cerrado

IMCIS Individualised medicine in chronic inflammatory skin disease... 1M€ Cerrado

PTQ-14-06856 Identificación, desarrollo y validación clínica de un sistem... 50K€ Cerrado

ARCAID Amsterdam Rheumatology Center for AutoImmune Diseases 4M€ Cerrado

STRATA-FIT Stratification of Rheumatoid Arthritis: CompuTational models... 6M€ Cerrado

Duración del proyecto: 61 meses Fecha Inicio: 2017-08-30
Fecha Fin: 2022-09-30

Líder del proyecto

AMC MEDICAL RESEARCH BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Background: EU countries face large health challenges to combat chronic diseases. Recently, systems medicine has emerged as a promising discipline to accelerate the translation of basic research into applications for improved diagnostics and personalized treatment. Its power arises from the integration of laboratory and computational approaches crossing research disciplines and sectors to solve clinical questions. COSMIC delivers the next generation of leading, entrepreneurial, and innovative systems medicine professionals having expertise, skills, and experience to successfully combat complex human disorders. These professional will find excellent career opportunities. COSMIC focuses on B-cell neoplasia and rheumatoid arthritis, prototypical diseases originating from abnormal functioning of immune cells, often resulting in similar antigen specificities. COSMIC enables Early Stage Researchers to play a leading role in this exciting field. Approach: COSMIC develops and integrate experimental and computational approaches and establish a unique cross-fertilization between oncology and auto-immunity. In addition to transferable skills, the training program focuses on establishing a double expertise in laboratory and computational to address clinical questions. It involves a wide-range of stakeholders: (pre)clinical departments, companies, patient groups, students, and the general public. COSMIC will establish a link with the leading European EASyM and ISBE initiatives, and aims to harmonize systems medicine training throughout Europe by connecting to other EU (Marie Curie systems medicine) training initiatives. Impact: COSMIC (i) significantly improves ESR career perspectives (ii) leads to new public-private collaborations increasing competitiveness for companies; (iii) contributes to future oncology and immunology medical care; (iv) contributes to the EU systems medicine best practices.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores